Caribou Biosciences annual operating margin
2019
2020
2021
2022
2023
2024
2025
Caribou Biosciences Operating Margin Growth & History (CRBU)
Caribou Biosciences's operating margin was −1,329.37% for fiscal 2025.
View full Caribou Biosciences company overviewCaribou Biosciences annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −1,329.37% | +337.79 pp |
| 2024 | 2024-12-31 | −1,667.16% | −1330.53 pp |
| 2023 | 2023-12-31 | −336.63% | +431.54 pp |
| 2022 | 2022-12-31 | −768.17% | −70.33 pp |
| 2021 | 2021-12-31 | −697.84% | −405.60 pp |
| 2020 | 2020-12-31 | −292.24% | +300.45 pp |
| 2019 | 2019-12-31 | −592.69% | — |
Caribou Biosciences quarterly operating margin
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −1,690.39% | +93.56 pp |
| Q1 2026 | 2026-03-31 | −1,096.37% | +727.39 pp |
| Q4 2025 | 2025-12-31 | −721.97% | +1149.72 pp |
| Q3 2025 | 2025-09-30 | −1,337.58% | +551.65 pp |
| Q2 2025 | 2025-06-30 | −1,783.95% | −528.15 pp |
| Q1 2025 | 2025-03-31 | −1,823.76% | +70.11 pp |
| Q4 2024 | 2024-12-31 | −1,871.69% | −819.36 pp |
| Q3 2024 | 2024-09-30 | −1,889.23% | −1827.39 pp |
| Q2 2024 | 2024-06-30 | −1,255.80% | −380.49 pp |
| Q1 2024 | 2024-03-31 | −1,893.87% | −1005.34 pp |
| Q4 2023 | 2023-12-31 | −1,052.33% | −224.11 pp |
| Q3 2023 | 2023-09-30 | −61.84% | +741.58 pp |
| Q2 2023 | 2023-06-30 | −875.31% | −197.09 pp |
| Q1 2023 | 2023-03-31 | −888.52% | −105.75 pp |
| Q4 2022 | 2022-12-31 | −828.22% | −76.99 pp |
| Q3 2022 | 2022-09-30 | −803.42% | −335.33 pp |
| Q2 2022 | 2022-06-30 | −678.22% | +403.35 pp |
| Q1 2022 | 2022-03-31 | −782.77% | +47.94 pp |
| Q4 2021 | 2021-12-31 | −751.23% | −64.34 pp |
| Q3 2021 | 2021-09-30 | −468.09% | −441.49 pp |
| Q2 2021 | 2021-06-30 | −1,081.57% | — |
| Q1 2021 | 2021-03-31 | −830.71% | — |
| Q3 2020 | 2020-09-30 | −686.89% | — |
| Q2 2020 | 2020-06-30 | −26.60% | — |
Caribou Biosciences operating margin trends
Over the last five reported fiscal years, Caribou Biosciences's operating margin decreased from −292.24% to −1,329.37%, a change of −1037.12 percentage points. The latest reported quarter, Q2 2026, shows −1,690.39%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Caribou Biosciences filings at SEC.gov ↗